Cargando…

Awareness of Pleiotropic and Cardioprotective Effect of Statins in Patients with Coronary Artery Disease

BACKGROUND: Statins are commonly used in the secondary prevention of coronary artery disease. Studies have shown that the rate of statin use is low among patients with coronary artery disease. In this study, we aimed to investigate the reasons for poor patient compliance with statin treatment. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozkan, Bugra, Örsçelik, Özcan, Uyar, Hakan, Ballı, Mehmet, Güçer, Eren, Aslan, Onur, Temel, Gülhan, Çelik, Ahmet, Türkay Özcan, İsmail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011107/
https://www.ncbi.nlm.nih.gov/pubmed/29977920
http://dx.doi.org/10.1155/2018/8961690
_version_ 1783333735020625920
author Ozkan, Bugra
Örsçelik, Özcan
Uyar, Hakan
Ballı, Mehmet
Güçer, Eren
Aslan, Onur
Temel, Gülhan
Çelik, Ahmet
Türkay Özcan, İsmail
author_facet Ozkan, Bugra
Örsçelik, Özcan
Uyar, Hakan
Ballı, Mehmet
Güçer, Eren
Aslan, Onur
Temel, Gülhan
Çelik, Ahmet
Türkay Özcan, İsmail
author_sort Ozkan, Bugra
collection PubMed
description BACKGROUND: Statins are commonly used in the secondary prevention of coronary artery disease. Studies have shown that the rate of statin use is low among patients with coronary artery disease. In this study, we aimed to investigate the reasons for poor patient compliance with statin treatment. METHODS: A total of 504 patients diagnosed with coronary heart disease were included in the study. Patients were asked 5 questions to assess their level of knowledge about statin therapy. RESULTS: Among the patients not using statins, 42% stated they did not take the medication because their cholesterol was not high or they did not know they should renew their prescription when they ran out and 35% because they were influenced by news reports in the media suggesting that cholesterol-lowering drugs were harmful. When patients who were aware of the pleiotropic/cardioprotective effects of statins were compared with patients who were not, the more knowledgeable patients had lower noncompliance rate and mean LDL-C level and a higher rate of LDL-C level optimization. CONCLUSION: We found that patients who are aware of the pleiotropic effects of statins were more compliant with treatment. We believe that spending more time explaining and emphasizing the mechanisms of action, reason for prescribing, and necessary treatment duration of drugs that patients must use will result in greater compliance and improve patient care. In this way, patients may be less influenced by misinformation presented by the media.
format Online
Article
Text
id pubmed-6011107
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-60111072018-07-05 Awareness of Pleiotropic and Cardioprotective Effect of Statins in Patients with Coronary Artery Disease Ozkan, Bugra Örsçelik, Özcan Uyar, Hakan Ballı, Mehmet Güçer, Eren Aslan, Onur Temel, Gülhan Çelik, Ahmet Türkay Özcan, İsmail Biomed Res Int Research Article BACKGROUND: Statins are commonly used in the secondary prevention of coronary artery disease. Studies have shown that the rate of statin use is low among patients with coronary artery disease. In this study, we aimed to investigate the reasons for poor patient compliance with statin treatment. METHODS: A total of 504 patients diagnosed with coronary heart disease were included in the study. Patients were asked 5 questions to assess their level of knowledge about statin therapy. RESULTS: Among the patients not using statins, 42% stated they did not take the medication because their cholesterol was not high or they did not know they should renew their prescription when they ran out and 35% because they were influenced by news reports in the media suggesting that cholesterol-lowering drugs were harmful. When patients who were aware of the pleiotropic/cardioprotective effects of statins were compared with patients who were not, the more knowledgeable patients had lower noncompliance rate and mean LDL-C level and a higher rate of LDL-C level optimization. CONCLUSION: We found that patients who are aware of the pleiotropic effects of statins were more compliant with treatment. We believe that spending more time explaining and emphasizing the mechanisms of action, reason for prescribing, and necessary treatment duration of drugs that patients must use will result in greater compliance and improve patient care. In this way, patients may be less influenced by misinformation presented by the media. Hindawi 2018-06-07 /pmc/articles/PMC6011107/ /pubmed/29977920 http://dx.doi.org/10.1155/2018/8961690 Text en Copyright © 2018 Bugra Ozkan et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ozkan, Bugra
Örsçelik, Özcan
Uyar, Hakan
Ballı, Mehmet
Güçer, Eren
Aslan, Onur
Temel, Gülhan
Çelik, Ahmet
Türkay Özcan, İsmail
Awareness of Pleiotropic and Cardioprotective Effect of Statins in Patients with Coronary Artery Disease
title Awareness of Pleiotropic and Cardioprotective Effect of Statins in Patients with Coronary Artery Disease
title_full Awareness of Pleiotropic and Cardioprotective Effect of Statins in Patients with Coronary Artery Disease
title_fullStr Awareness of Pleiotropic and Cardioprotective Effect of Statins in Patients with Coronary Artery Disease
title_full_unstemmed Awareness of Pleiotropic and Cardioprotective Effect of Statins in Patients with Coronary Artery Disease
title_short Awareness of Pleiotropic and Cardioprotective Effect of Statins in Patients with Coronary Artery Disease
title_sort awareness of pleiotropic and cardioprotective effect of statins in patients with coronary artery disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011107/
https://www.ncbi.nlm.nih.gov/pubmed/29977920
http://dx.doi.org/10.1155/2018/8961690
work_keys_str_mv AT ozkanbugra awarenessofpleiotropicandcardioprotectiveeffectofstatinsinpatientswithcoronaryarterydisease
AT orscelikozcan awarenessofpleiotropicandcardioprotectiveeffectofstatinsinpatientswithcoronaryarterydisease
AT uyarhakan awarenessofpleiotropicandcardioprotectiveeffectofstatinsinpatientswithcoronaryarterydisease
AT ballımehmet awarenessofpleiotropicandcardioprotectiveeffectofstatinsinpatientswithcoronaryarterydisease
AT gucereren awarenessofpleiotropicandcardioprotectiveeffectofstatinsinpatientswithcoronaryarterydisease
AT aslanonur awarenessofpleiotropicandcardioprotectiveeffectofstatinsinpatientswithcoronaryarterydisease
AT temelgulhan awarenessofpleiotropicandcardioprotectiveeffectofstatinsinpatientswithcoronaryarterydisease
AT celikahmet awarenessofpleiotropicandcardioprotectiveeffectofstatinsinpatientswithcoronaryarterydisease
AT turkayozcanismail awarenessofpleiotropicandcardioprotectiveeffectofstatinsinpatientswithcoronaryarterydisease